JLHL vs MEDANTA: Stock Comparison

JUPITER LIFE LINE HOSP L vs GLOBAL HEALTHUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

GLOBAL HEALTH is the larger company by market capitalisation. JUPITER LIFE LINE HOSP L shows a lower P/E, a higher ROE and a higher dividend yield, while GLOBAL HEALTH shows faster revenue growth, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

JLHL leads 7; MEDANTA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

JLHLMEDANTA

Valuation lens

What price are you paying?

Market CapContext only
₹9,145 Cr
₹38,774 Cr
P/E RatioJLHL has the lower reading
49.11x
69.7x
P/B RatioJLHL has the lower reading
5.92x
9.78x
EPSMEDANTA has the higher reading
₹1.14
₹5.9
Book ValueContext only
₹47.1
₹148.18
Dividend YieldJLHL has the higher reading
0.36%
0.03%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MEDANTA is the larger company
₹38,774 Cr vs ₹9,145 Cr
P/E Ratio
JLHL has a lower P/E
49.11x vs 69.7x
P/B Ratio
JLHL has a lower P/B
5.92x vs 9.78x
EPS
MEDANTA has higher earnings per share
₹5.9 vs ₹1.14
Dividend Yield
JLHL has a higher dividend yield
0.36% vs 0.03%
Revenue Growth (TTM YoY)
MEDANTA has faster revenue growth
24.5% vs 17.1%
EPS Growth (TTM YoY)
MEDANTA has faster EPS growth
42% vs 12%
Qtr Sales Growth
JLHL has stronger quarterly sales growth
25.11% vs 20.89%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJLHLMEDANTA
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricJLHLMEDANTA
Live Price₹279.15₹1,447.2
Day Change-0.66%-0.85%
Volume78,42774,678
52-Week High₹1,625₹1,544
52-Week Low₹279₹956
Distance from 52W High-82.82%-6.27%

Valuation

MetricJLHLMEDANTA
Market Cap₹9,145 Cr₹38,774 Cr
P/E Ratio49.11x69.7x
P/B Ratio5.92x9.78x
EPS₹1.14₹5.9
Book Value₹47.1₹148.18
Dividend Yield0.36%0.03%

Growth

MetricJLHLMEDANTA
Revenue Growth (TTM YoY)17.1%24.5%
EPS Growth (TTM YoY)12%42%
Qtr Sales Growth25.11%20.89%
Qtr Profit Growth0.87%14.53%

Profitability & Leverage

MetricJLHLMEDANTA
ROE12.47%12.37%
ROCE10.77%11.4%
Net Margin13.01%12.62%
Operating Margin19.5%18.62%
Debt to Equity0.33x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricJLHLMEDANTA
Promoter Holding40.91%33% 0.01 pp
FII Holding9.37% 0.89 pp9.46% 0.69 pp
DII Holding16.51% 0.5 pp16.89% 2.13 pp
Public Holding33.21% 0.39 pp40.56% 1.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JUPITER LIFE LINE HOSP L and GLOBAL HEALTH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.